BioCentury | Jan 17, 2019
Emerging Company Profile

Zelluna’s solid TCR plans

...portfolio of TCRs against antigens that are critical to tumor survival: TERT, KRAS and TGFBR2. Oslo University Hospital...
...direct cytolytic approach preferable. Zelluna has in-licensed the TCRs that ZI-H04 and ZI-T01 express from Oslo University Hospital...
...focus: Cancer Clinical status: Preclinical Founded: 2016 by Radforsk, Birk Venture and Inven2 University collaborators: Oslo University Hospital...
BioCentury | Dec 4, 2018
Distillery Therapeutics

Neurology

...online Oct. 25, 2018 doi:10.1124/jpet.118.251504 CONTACT: Inger Lise Bogen, Oslo University Hospital, Oslo, Norway email: inger.lise.bogen@ous-hf.no Jaime De Leon Oslo University Hospital 6-monoacetylmorphine Addiction...
BioCentury | Oct 25, 2018
Distillery Techniques

Biomarkers

...julio.aguirre-ghiso@mssm.edu CONTACT: Bjørn Naume, Oslo University Hospital, Oslo, Norway email: BNA@ous-hf.no Sandi Wong Icahn School of Medicine at Mount Sinai Oslo University Hospital Nuclear...
BioCentury | Aug 1, 2013
Targets & Mechanisms

Prostate cancer's nerves

...that sensory neurons stimulate prostate cancer proliferation in vitro . 4 This year, researchers at Oslo University Hospital...
...University of York . Maitland and Kristin Austlid Taskén, an adjunct professor of urology at Oslo University Hospital...
...Center , Durham, N.C. Icahn School of Medicine at Mount Sinai , New York, N.Y. Oslo University Hospital...
BioCentury | May 13, 2013
Emerging Company Profile

Ultimovacs: hTERT redux

...patient survival. The most advanced hTERT-targeting vaccine in the clinic, GV1001 , was developed by Oslo University Hospital...
...Turin, Italy Kael Co. Ltd. (KOSDAQ:082270), Daejon, South Korea Mediolanum Farmaceutici S.p.A. , Milan, Italy Oslo University Hospital...
...Phase I/IIa Founded: 2011 by Gustav Gaudernack, Else Marit Inderberg Suso, Anne-Marie Rasmussen University collaborators: Oslo University Hospital...
BioCentury | Apr 18, 2013
Cover Story

Targeting tankyrase

...professor of microbiology at the University of Oslo and director of stem cell signaling at Oslo University Hospital...
...Switzerland Novartis Institutes for BioMedical Research , Basel, Switzerland Odin Therapeutics A/S , Oslo, Norway Oslo University Hospital...
...et al. J. Med. Chem. ; published online March 11, 2013; doi:10.1021/jm4000566 Contact: Stefan Krauss, Oslo University Hospital...
BioCentury | Apr 11, 2013
Distillery Therapeutics

Indication: Cancer

...A. et al. J. Med. Chem.; published online March 11, 2013; doi:10.1021/jm4000566 Contact: Stefan Krauss, Oslo University Hospital...
BioCentury | Nov 12, 2012
Emerging Company Profile

Targovax: Ras to the rescue

...published in the 1990s, research teams led by Gustav Gaudernack at Norwegian Radium Hospital (now Oslo University Hospital...
...Institutions Mentioned Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Norsk Hydro ASA , Oslo, Norway Oslo University Hospital...
...by Gustav Gaudernack, Jon Amund Eriksen and the Norwegian Radium Hospital Research Foundation University collaborators: Oslo University Hospital...
BioCentury | Apr 12, 2012
Distillery Therapeutics

Indication: Cancer

...Waaler, J. et al. Cancer Res.; published online March 22, 2012; doi:10.1158/0008-5472.CAN-11-3336 Contact: Jo Waaler, Oslo University Hospital...
BioCentury | Jul 26, 2010
Company News

OvaGene Oncology, Inven 2 AS deal

...to detect chemoradiation resistance in cervical cancer patients. Inven2 is a technology transfer office representing Oslo University Hospital...
Items per page:
1 - 10 of 10
BioCentury | Jan 17, 2019
Emerging Company Profile

Zelluna’s solid TCR plans

...portfolio of TCRs against antigens that are critical to tumor survival: TERT, KRAS and TGFBR2. Oslo University Hospital...
...direct cytolytic approach preferable. Zelluna has in-licensed the TCRs that ZI-H04 and ZI-T01 express from Oslo University Hospital...
...focus: Cancer Clinical status: Preclinical Founded: 2016 by Radforsk, Birk Venture and Inven2 University collaborators: Oslo University Hospital...
BioCentury | Dec 4, 2018
Distillery Therapeutics

Neurology

...online Oct. 25, 2018 doi:10.1124/jpet.118.251504 CONTACT: Inger Lise Bogen, Oslo University Hospital, Oslo, Norway email: inger.lise.bogen@ous-hf.no Jaime De Leon Oslo University Hospital 6-monoacetylmorphine Addiction...
BioCentury | Oct 25, 2018
Distillery Techniques

Biomarkers

...julio.aguirre-ghiso@mssm.edu CONTACT: Bjørn Naume, Oslo University Hospital, Oslo, Norway email: BNA@ous-hf.no Sandi Wong Icahn School of Medicine at Mount Sinai Oslo University Hospital Nuclear...
BioCentury | Aug 1, 2013
Targets & Mechanisms

Prostate cancer's nerves

...that sensory neurons stimulate prostate cancer proliferation in vitro . 4 This year, researchers at Oslo University Hospital...
...University of York . Maitland and Kristin Austlid Taskén, an adjunct professor of urology at Oslo University Hospital...
...Center , Durham, N.C. Icahn School of Medicine at Mount Sinai , New York, N.Y. Oslo University Hospital...
BioCentury | May 13, 2013
Emerging Company Profile

Ultimovacs: hTERT redux

...patient survival. The most advanced hTERT-targeting vaccine in the clinic, GV1001 , was developed by Oslo University Hospital...
...Turin, Italy Kael Co. Ltd. (KOSDAQ:082270), Daejon, South Korea Mediolanum Farmaceutici S.p.A. , Milan, Italy Oslo University Hospital...
...Phase I/IIa Founded: 2011 by Gustav Gaudernack, Else Marit Inderberg Suso, Anne-Marie Rasmussen University collaborators: Oslo University Hospital...
BioCentury | Apr 18, 2013
Cover Story

Targeting tankyrase

...professor of microbiology at the University of Oslo and director of stem cell signaling at Oslo University Hospital...
...Switzerland Novartis Institutes for BioMedical Research , Basel, Switzerland Odin Therapeutics A/S , Oslo, Norway Oslo University Hospital...
...et al. J. Med. Chem. ; published online March 11, 2013; doi:10.1021/jm4000566 Contact: Stefan Krauss, Oslo University Hospital...
BioCentury | Apr 11, 2013
Distillery Therapeutics

Indication: Cancer

...A. et al. J. Med. Chem.; published online March 11, 2013; doi:10.1021/jm4000566 Contact: Stefan Krauss, Oslo University Hospital...
BioCentury | Nov 12, 2012
Emerging Company Profile

Targovax: Ras to the rescue

...published in the 1990s, research teams led by Gustav Gaudernack at Norwegian Radium Hospital (now Oslo University Hospital...
...Institutions Mentioned Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Norsk Hydro ASA , Oslo, Norway Oslo University Hospital...
...by Gustav Gaudernack, Jon Amund Eriksen and the Norwegian Radium Hospital Research Foundation University collaborators: Oslo University Hospital...
BioCentury | Apr 12, 2012
Distillery Therapeutics

Indication: Cancer

...Waaler, J. et al. Cancer Res.; published online March 22, 2012; doi:10.1158/0008-5472.CAN-11-3336 Contact: Jo Waaler, Oslo University Hospital...
BioCentury | Jul 26, 2010
Company News

OvaGene Oncology, Inven 2 AS deal

...to detect chemoradiation resistance in cervical cancer patients. Inven2 is a technology transfer office representing Oslo University Hospital...
Items per page:
1 - 10 of 10